You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Predicting interactions of rifampin and antihypertensive drugs using BDDCS
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-HPS-048
- By: LIU, Wei (Peking University Third Hospital, Pharmacy Department, Beijing, China)
- Co-author(s): Tingting Yan:Pharmacy Department,Peking University Third Hospital,Beijing,China|Wei Liu:|Ken Chen:Pharmacy Department,Peking University Third Hospital,Beijing,China|Li Yang:Pharmacy Department,Peking University Third Hospital,Beijing,China|Leslie Benet:Department of Pharmacy,University of California, San Francisco,San Francisco,United States|Suodi Zhai:Pharmacy Department,Peking University Third Hospital,Beijing,China
- Abstract:
Lack of blood pressure control is often seen in hypertensive patients concomitantly taking antituberculosis (anti-TB) medications due to the complex drug-drug interactions (DDI) between rifampin and antihypertensive drugs.
Antihypertensive drugs were classified into 4 categories under BDDCS Classifications. Predictions were made under the theory
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026